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Summary B-cell colony growth of malignant and normal B-cells has been studied in a double layer (agar-
fluid) colony assay. Stimulatory factors consisted of irradiated blood leukocytes, phytohaemagglutinin (PHA),
interleukin 2 (IL2) and 12-0-tetradecanoylphorbol-13-acetate (TPA) in various combinations. B-cell colonies
have been obtained in all cases tested, i.e., 7/7 cases with chronic lymphocytic leukaemia, 7/7 cases with non-
Hodgkin's lymphoma, 5/5 cases with hairy cell leukaemia and 7/7 normal B-cell suspensions, obtained from
blood ( x 3), bone marrow ( x 2) and spleen ( x 2). The plating efficacy ranged from 0.02-0.35, with a median
of 0.07. Colony formation was found to be linear (r =0.96) in the plating range of 0.5-8 x 105 cells. Secondary
colonies could be obtained in 2 cases tested. DNA synthesizing cells in colonies were determined in 4 cases
using monoclonal antibodies against DNA-incorporated bromodeoxyuridine (BrdUrd). In most cases the
combination of PHA (with or without IL2) and irradiated leukocytes yielded the highest number of colonies,
but in some experiments stimulation with TPA+IL2 was found to be optimal.
An in vitro clonogenic assay for malignant B-cells can serve
several purposes. Cytostatic therapy can be monitored and
the optimal technique for 'purging' of bone marrow (BM)
for autologous bone marrow transplantation (ABMT) with
monoclonal antibodies (MCA) and complement can be
evaluated. When the clonogenic assay is very sensitive it can
be used for staging purposes- and detection of minimal
residual disease. Finally, the in vitro growth characteristics of
a variety of B-cell malignancies can be studied and related to
clinical patterns and prognosis.
Several B-cell colony assays have been described
(Hamburger & Salmon, 1977; Jones et al., 1979; Izaguirre et
al., 1980; Bobak & Whisler, 1980; Smith et al., 1981; Fay et
al., 1985; Touw et al., 1985a, b). In one of these (Touw &
L6wenberg, 1985a; Touw et al., 1985b) excellent colony
formation of non-T acute lymphoblastic leukaemia (non T-
ALL) and B-cell chronic lymphocytic leukaemia (CLL) was
obtained after addition of interleukin 2 (IL2) and phyto-
haemagglutinin (PHA) or the phorbol ester 12-0-tetra-
decanoylphorbol-13-acetate (TPA) to the culture system.
In this PHA leukocyte feeder colony assay (Lowenberg et
al., 1980), we studied the culture conditions for colony
formation of CLL, B-cell non-Hodgkin's lymphoma (NHL),
hairy cell leukaemia (HCL) and of normal B-cells obtained
from blood, BM and spleen. In all cases malignant and
normal clonogenic B-cells could be successfully grown.
Materials and methods
Patients and isolation ofcells
Malignant B-cells were studied from 7 patients with CLL
(x 7 blood), one of them with prolymphocytic trans-
formation, from 7 patients with NHL (x 7 leukaemic blood),
classified according to Lennert (1978) as immunocytoma
(lymphoplasmacytoid) (4 patients), small centrocytic (1
patient) and intermediate-type NHL as described by Berard
(Weissenburger et al., 1981) (2 patients), and from 6 patients
with HCL (x 3 spleen, x 3 blood). Normal B-cells were
obtained from blood of 3 healthy donors, from cytomorpho-
logically normal bone marrow of 2 patients who underwent
general anaesthesia for minor surgery and from the spleen of
a kidney donor and of a patient who underwent splenectomy
for idiopathic thrombocytopenic purpura. In the latter case
stimulated polyclonal B-cell follicles were present in the
spleen; otherwise no abnormalities were found.
Single cell suspensions from the spleen were obtained by
gentle mechanical disruption only. Mononuclear cells were
isolated from blood, BM and spleen by Ficoll-Isopaque
(d= 1.077) density gradient centrifugation. Non-T-cell
fractions were obtained by rosetting with 2-aminoethylthio-
uroniumbromide-hydrobromide-treated sheep red blood cells
(Eaet; Madson & Johnson, 1979) and subsequent separation
by Ficoll-Isopaque centrifugation. When necessary this pro-
cedure was repeated once until the percentage of residual T-
cells, as assessed by reactivity with the MCA CD2 (leu-5)
and CD3 (leu-4) (Becton Dickinson, Mountain View, CA,
USA), was <0.5. To reduce the large contribution of
monocytes to the non-T-cell fraction of blood from the
normal donors, monocytes were depleted by carbonyl iron
incorporation (Grade SF, Aristopham, Delft, The
Netherlands) (Lundgren et al., 1968). In many instances the
mononuclear cells or the purified non-T-cells were frozen in
RPMI 1640 (Gibco, Grand Island, USA) containing 25%
foetal calf serum (FCS, Gibco) and 10% DMSO. After
minimal 6h in -70°C the cells were transferred to liquid
nitrogen. After thawing, the viable recovery as assessed by
trypan blue exclusion, varied from 28-95%. No relationship
between viability and subsequent colony growth was found.
Colony assay
Colony cultures were performed as described (Lowenberg et
al., 1980). Briefly, 2 x 105 viable non-T-cells in single cell
suspension were plated in 35mm Petri dishes in 0.4ml liquid
culture medium supplemented with 3.2ug PHA (Wellcome,
Dartford) or 10-1,000 ng TPA (Sigma, St. Louis, MO, USA)
and/or 25 U leukocyte-derived IL2 (kindly provided by Dr
L. Aarden, Central Laboratory of the Netherlands Red
Cross Blood Transfusion Service, Amsterdam, The Nether-
lands) or highly purified leukocyte-derived IL2 (TCGF-HP,
Biotest, Dreieich, FRG) on top of a 1 ml 0.5% agar under-
layer with or without 2 x 106 irradiated (25Gy) normal
blood leukocytes in culture medium. The culture medium
consisted of Iscove's modified Dulbecco's medium (IMDM,
Gibco) supplemented with FCS (6.7%, Rehatuin, Kankakee,
IL, USA), horse serum (6.7%, Flow Laboratories, Irvine,
Scotland, UK), trypticase soy broth (6.7%, Becton Dickinson)
and a mixture (10%) of bovine serum albumin (10%, Sigma),
egg lecithin (3.75 x l0-3 M, Merck, Darmstadt, FRG),
human transferrin (9.62 x 10-4 M, Behringwerke, Hoechst,
Amsterdam, The Netherlands) in a FeCl3 solution (1.92x
10-3 M), IMDM and f,-mercaptoethanol (10-1M) in
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ratios of respectively 75:8:8:8:1. The cells were always
plated on underlayers with and without leukocyte feeders.
Triplicate cultures were incubated at 37°C in a humidified
5% CO2 atmosphere. Colonies (spherical-shaped, strongly
coherent aggregates of 50 cells or more) were counted on
day 5-7 of culture by use of an inverted microscope. Mean
values ofcolony numbers from triplicate cultures are given.
Analysis ofcolonies
Colony cells were mass-harvested with a Pasteur pipette,
washed and prepared for Eaet-rosette formation, morpho-
logical and cytochemical analysis such as May-Grunwald
Giemsa (MGG), alpha-naphtyl acetate esterase (ANAE),
(Yam et al., 1971), peroxidase and tartrate resistant acid
phosphatase (TRAP) according to Janckila et al. (1978) and
immunofluorescence. In most studies whole colonies were
harvested and carefully spun down through a layer of PBS
and 20% FCS.
Fluorescence studies were performed on cells in suspension
and on cytocentrifuged cells. Commercial fluorescein- and
rhodamin-conjugated antisera to human light immuno-
globulin chains (Kallestad, Austin, TX, USA) were used to
detect surface and cytoplasmic immunoglobulins (SmIg, clg).
In some experiments the reactivity with CDl9 (B4) or CD20
(Bl) (Coulter Electronics, Hialeah, FL, USA) was deter-
mined. Binding with murine MCA was assessed with
fluorescein-conjugated goat-anti-mouse Ig (Nordic, Tilburg,
The Netherlands). The percentage of positive cells was
scored by microscope (Leitz dialux, equipped with phase-
contrast and with the Ploemopak 2.3 illuminator). At least
100-200 colony cells were counted.
Cytogenetic analysis
Colonies were analysed at day 3-5 of culture. Colchicine
(0.008 jgml-1 final concentration) and ethidium bromide
(0.02 mgml -1 final concentration) were added to the
cultures 2h before harvesting. In some cases a low tempera-
ture culture technique was employed for growth arrest and
synchronization (Enninga et al., 1984) whereby cultures were
kept at 33°C for 24h followed by a recovery period at 37°C
of 12-16h before the addition of colchicine and ethidium
bromide. Chromosome preparations were made according to
standard techniques.
BrdUrd incorporation
Bromodeoxyuridine (BrdUrd, Sigma), was added (1OgM final
concentration) for 1, 6, 24 or 48 h to colony cultures from
the 3rd to 5th culture day in 4 experiments (1 xCCL,
2 x NHL, 1 x HCL). After the addition of BrdUrd, the
cultures were protected from UV irradiation. Whole colonies
were mass-harvested and cytocentrifuge slides were prepared.
Hydrolysis of DNA and nuclear protein was performed by
incubation in 0.07N NaOH for 15min, followed by
dehydration in a graded series of ethanol and subsequently
treated with 0.1 mgml- I proteinase-K (Boehringer,
Mannheim, FRG) in 10mM Tris-HCL, 2mM CaCl2, pH7.0,
for 10min at room temperature. After further dehydration in
ethanol, the slides were pre-incubated in PBS containing
0.5% bovine serum albumin and 0.1% Tween 20 for 30min
and then incubated for 1 h with a 1:3,000 dilution of a
purified anti-BrdUrd MCA (IU-4, a generous gift from Dr
Frank Dolbeare, Livermore, CA, USA). After rinsing in
PBS, the slides were covered with an 1:40 dilution of a
peroxidase-conjugated rabbit-anti-mouse IgG antibody
(Dakopatts, Glostrup, Denmark) for 30min, rinsed again
with PBS and reacted for 10-15min with diaminobenzidine
and H202. As a control, the same procedure was used,
omitting the IU-4 incubation step. The slides were lightly
counterstained with hematoxylin. Cells (103) were counted to
determine labelling indices.
Results
Chronic lymphocytic leukaemia
Frozen blood cells of 7 patients were studied. In all cases
colonies were obtained (Figure 1). The case with prolympho-
cytic transformation of CLL showed the highest number of
colonies (up to 350/105). The plating efficacy (PE) ranged
from 0.02-0.35, with a median of 0.05. The colonies
consisted of small cells and ranged from 50 to several
thousands of cells (Figure 2).
Analysis of the colony cells yielded <0.5-3% Eaet-rosette
positive cells. By cytomorphology, a colony was found to
consist of blastoid, lymphoplasmacytoid and small lympho-
cytic cells with 'Grumulee' pattern (Table I). In the ANAE
stain, many colonies contained in their centres either one
or more strongly positive monocytic cells. By immuno-
fluorescence studies, monotypic (i.e. light-chain restricted)
cytoplasmic immunoglobulins were present in all cases tested
(Table I). The clg light chain, usually present in >80% of
colony cells was always similar to the SmIg light chain
before culture. The complementary light chain was always
absent. In 4 patients, reactivity with CD19 or CD20 MCA
showed that more than 72% of the colony cells were B-cells.
Non-Hodgkin's lymphoma
Colony formation was obtained in all cases tested (Figure 1). The PE ranged from 0.03-0.13, with a median of 0.07. With
only one exception (lymphoplasmacytoid NHL) frozen cells
were used. In the majority (5/7) stimulation with TPA+IL2
was optimal. In 2 cases analysis of the colonies showed
rather high percentages of Eaet-rosette-binding cells (23 and
33) when stimulated with PHA. TPA-stimulated colony
cultures of these cases yielded at the same time lower
percentages of Eaet-rosettes (12 and 14 respectively). By
cytomorphology, lymphoma cell characteristics such as
centrocytes in the patient with diffuse centrocytic lymphoma
and plasmacytoid cells in the 3 cases with immunocytoma
could be clearly recognised (Figure 2, Table I). ANAE
staining of whole colonies showed - similarly to the CLL
colonies - often one strongly positive cell centrally located.
In all cases tested cytoplasmic light chain-restricted immuno-
globulins were present in the colony cells (Table I).
Hairy cell leukaemia
In one out of 6 patients, T-cell depletion by Eaet-rosetting
was unsuccessful, due to stickiness of the hairy cells. In the
remaining five cases purified non-T suspensions were
obtained. Colonies could be easily grown, in two cases from
blood and in three cases from frozen spleen cells (Figure 1).
The PE ranged from 0.03-0.16, with a median of 0.05. The
colonies were often very large and consisted of large cells. In
contrast to colonies grown from other B-cell malignancies
and normal B-cells, the hairy cell colonies did not always
float freely in the fluid upperlayer, but strongly adhered to
the agar underlayer.
The % Eaet rosettes of colony cells was below 12.
However, in one case using spleen cells, a significant
percentage Eaet-rosetting cells was found (PHA stimulated
cultures=44%; TPA stimulated cultures=14%). Morpho-
logically, the colonies consisted of plasmablasts, plasma cells
and hairy cells (Figure 2, Table I) with long hairy pro-
trusions of the cytoplasm, especially in the TPA stimulated
cultures. Cytochemically the cells were peroxidase and
ANAE negative. Strong TRAP positivity was present (Figure'
2). By immunofluoresence, small amounts of light-chain
restricted clg were found.
Normal B-cells
The numbers of colonies grown from fresh and cryo-
preserved non-T-cell suspensions, isolated from blood, BM
and spleen are given in Table II. Colony analysis showed inB-CELL COLONIES OF MALIGNANT AND NORMAL B-CELLS 399
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Figure Colony formation of B-CLL (n = 7), B-NHL (n =7) and HCL (n = 5). Cells were stimulated in the PHA-leukocyte
feeder assay with PHA, TPA and IL2 in various combinations. Each dot represents the mean value of a triplicate culture.
A-CLL; * NHL; * HCL.
one case a considerable amount of Eaet-rosetting cells in the
colonies grown from blood. Despite T-cell depletion by
repeated Eaet-rosetting procedures, 1% residual CD3+ cells
were left in this case. However, when this cell suspension was
frozen, thawed and recultured, the percentage of Eaet-rosette
positive colony cells was much lower (Table II). When fresh
and frozen BM cells were compared, this phenomenon was
also seen.
Further analysis of the colonies showed low numbers of
peroxidase and ANAE positive cells, sometimes centrally
positioned in a colony. By cytomorphology, a mixed
lymphocytic population was seen, with large blasts,
plasmacytoid cells and more mature small lymphocytes. The
colonies often were very adherent, which hampered detailed
morphological identification of individual cells.
By immunofluorescence, colony cells expressed either
kappa or lambda chains in the cytoplasm. Whole colonies
contained variable amounts of cIg+ cells, which is in
accordance with the heterogeneous composition found with
MGG and ANAE stains.
Growth characteristics ofcolonies
Linear colony formation was found when HCL cells were
plated in varying numbers ranging from 0.5 to 8 x I05
(r=0.96). The number of colonies ranged from 26+9 (lowest
cell concentration) to 355 +55 (highest cell concentration).
At these cell numbers no plateau was reached.
Secondary colonies were obtained in the two cases tested
(CLL x 1, HCL x 1). To grow these, 6-day-old colonies were
counted, mass-harvested, mechanically disrupted and cells of
80, 160 or 320 colonies were replated in single cell
suspension. The numbers of secondary colonies thus
obtained after 6 days, were expressed as secondary colony
per 'first colony' plated. Linearity of secondary growth was
found, albeit in the small range of cell numbers plated. For
CLL colonies, we found 0.29-0.54 (mean 0.40) secondary
colonies/first colonies. For HCL, the ratio of secondary
colonies/first colonies ranged from 0.15-0.37 (mean 0.29).
Analysis of the secondary colonies in the case of CLL
yielded - identically to the primary colonies - <0.5% Eaet-
rosettes, >80% BI reactivity and 85% strong kappa
positivity.
In order to demonstrate cell growth and to exclude the
possibility that colony formation was solely a result of
cellular aggregation, colony cells were screened for the
presence of metaphases and BrdUrd incorporation was also
studied. Cytogenetic analysis showed metaphases after PHA
and/or TPA stimulation in 4 cases with CLL, I case with
prolymphocytic leukaemia, 3 cases with NHL and 3 cases
with HCL. A representative picture is given in Figure 3.
BrdUrd incorporation was determined in 4 experiments of
different B-cell malignancies. In all cases a significant
number of immunoperoxidase stained nuclei could be
demonstrated (Figure 4). Endogenous peroxidase activity
was excluded in control experiments without the anti-
BrdUrd MCA. More positive cells were seen when BrdUrd
had been present in the cultures for a longer period (Table
III). The labeling percentages of both CLL and NHL
malignancies were found to be indicative of a pronounced
proliferative activity, whereas the labeling index of the HCL
case was relatively low.
We studied the influence of leukocyte feeders in the agar
underlayer by comparing cultures performed in the presence
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Figure 2 A: CLL colony; stimulation with PHA+IL2. Phase contrast (x 125). B: NHL colony, centrocytic; stimulation with
TPA+IL2; MGG ( x 780). Arrows point to characteristic clefts in the nuclei. C: HCL colony; stimulation with PHA+IL2; MGG
(x 780). D: HCL colony; stimulation with PHA+IL2; TRAP (x 780). E: HCL colony; stimulation with TPA+IL2; MGG
(x780).
Figure 3 Metaphase pattern in prolymphocytic leukaemia colony cells
and TPA+IL2 (B) ( x 780).
obtained after stimulation with PHA+IL2 (A), (x 720)
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Composition ofcells plated Analysis ofcolonies (mass-harvested)
% Mono- % T % Mono- % B
Morphology cytes (CD2+/ Morphology cytes (CD19+/ %T
Patients Diagnosis (MGG stain) (ANAE) slg CD3+) (MGG stain) (ANAE) % clg CD20+) (E ros+)
CLL >99% CLL
cells
CLL 97% CLL
cells
CLL 98% CLL
cells
CLL 97% CLL
cells
CLL >99% CLL
cells
CLL- 17% small
PLL lymphocytes,
transf.a >82% pro-
lymphocytes
CLL 99% CLL
cells
Case 8 NHL-CC 97% small
and medium
sized cleaved
cells
Case 9 NHL-LPL >98% NHL
cells
Case 10 NHL-LPL >98% NHL
cells
Case 11 NHL-LPL >98% NHL
cells,
mixture of
small and
medium sized
Case 12 NHL-ILL >98% NHL
cells,
partially
multilobated
0.5 U, K <0.5 majority lymphoplasmacytoid
cells
1 6, ,K <0.5 majority small lymphoid
cells; 10-30% blasts and
plasmactyoid cells
0.5 6, , K <0.5 25-60% small lymphoid
cells; 15-55% plasmacytoid
cells; 5-10% blasts; 5-10%
monocytes
1.5 ntb <0.5 majority small lymphoid
cells, admixed with blasts
1 6, ju, A <0.5 majority small lymphoid
cells, partially plasma-
cytoid
<0.5 6, Ai, 0.5 +50% prolymphocytes; 30-400%
small lymphoid cells or
blasts; 10-20% monocytes
0.5 6, Ai. <0.5 majority lymphoplasmacytoid
cells
1 a, 1 <0.5 majority (>g80%) centrocytes
with + 10% blasts
1.5 a, Pi, K 0.5 65-80% lymphoplasmacytoid;
5-10% blasts; 10-20% pro-
lymphocytes; 6% myelo-
monocytic
1 6, i,,K <0.5 majority lymphoplasma-
cytoid
1 6, u, A 2 majority large plasmacytoid
cells
<0.5 6, y, A <0.5 majority multilobated
lymphocytes
nt 80K
no A
nt 85K
no A
nt 65-75 K
no A
33 nt nt 0-3
8 81A
no K
4-9 82-96
no K
8 93A
no K
0 812
no K
nt 92 K
no A
0 77K
no A
5 72A
no K
0-1 13-53A
no K
Case 13 NHL-ILL >98%
multi- 1 y, K 0.5 majority multilobated
lobated lymphocytes
cells
Case 14 NHL-LPL mixture of 0.5 , K <0.5 majority large basophilic cells
cleaved cells, with multilobated
prolymphocytes nuclei
lymphoplasma-
cytoid cells and
plasma cells
Case 15 HCL 93% HCL 1 a , y, K 1 majority strongly basophilic
(blood) cells plasmacytoid cells
Case 16 HCL >98% HCL 0 a, y, A <0.5 majority large, partially
(spleen) cells; basophilic cells, intermediate
some plasma between HCL and plasma cells
cells
Case 17 HCL 92% HCL 1 a, 6, y, A <0.5 mixed hairy cells and
(spleen) cells, basophilic plasmacytoid
4% small cells, after TPA many cells
lymphocytes, with phagocytosed eosinophilic
4% myelo/ material
mono
Case 18 HCL 96% HCL <0.5 y, A <0.5 majority hairy cells,
(blood) cells admixed with more basophilic
plasmacytoid cells; after
TPA some monocytic cells
Case 19 HCL 97% HCL <0.5 a, Y, K <0.5 mixed hairy cells and
(spleen) cells basophilic plasmacytoid
cells
nt nt nt 1
4-5 74K
no A
>80 1-3
nt ntc ntc 0-0.5
8 nt nt 4
6-25 +30-50A
no K
1-6 96A
no K
6 >70K
no A
nt 14-44
78 0-5
96 10-12
Case 1
Case 2
Case 3
Case 4
Case 5
Case 6
Case 7
nt nt
>80 1
72 5-10
73 0
nt 0-3
90 0-1
>80 14-23
nt 0-1.5
nt 0-3
>80 12-33
nt 10-15
'PLL Transf. =prolymphocytic transformation; NHL-CC=centrocytic non-Hodgkin's lymphoma; LPL =lymphoplasmacytoid lymphoma;
ILL=intermediate lymphocytic lymphoma; bnt =not tested; Ca second time >50% CK and 81% CD19+ was found.
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Table II Colony formation of normal T-cell depleted blood, bone marrow and spleen cells
Number ofcolonies per 105 cells plated Colony analysis
% E ros. % E ros.
PHA TPA
None ILI PHA +IL2 PHA TPA +IL2 TPA cultures cultures
- non-T blood fresh 0 3 67 70 99 0 52 34
idem after N a 0 1 25 16 24 2 17 10
- non-T blood after N2 0 5 86 100 0
- non-T blood after N2 lb 1 1 3 58 42 0.5
- non-T BM fresh 52b 39 344 52
- non-T BM fresh 4b 19 125 147 21 23
idem after N2 1 17 138 81 53 2 0.5 0.5
- non-T spleen fresh 1 43 80 81 14 19 7
idem after N2 1 17 47 43
- non-T spleen after N2 0 22 113 90 70 65 15 6
aN2=after freezing in liquid nitrogen; b myeloid growth.
Table III BrdUrd incorporation in malignant B-cell colony cells
Diagnosis Stimulation Percent ofcolony cells positivefor BrdUrda
I h 6h 24h 48h
CLL PHA+IL2+ feeder cells 16.7b 19.2 32.8
NHL-ILLC TPA+IL2+feeder cells 8.5 26.0
NHL-ILL in transf. PHA+IL2+feeder cells 7.4 10.5 18.1 22.0
HCL PHA+ L2+feeder cells 7.3 12.0
aBrdUrd was present in the culture for 1, 6, 24 or 48h during day 3-5: b1,000 cells were counted in
each experiment; CILL=intermediate lymphocytic lymphoma.
A.." B.::
Figure 4 BrdUrd incorporation, visualised by binding with peroxidase-conjugated rabbit-anti-mouse IgG. A: CLL colony;
stimulation with PHA+IL2+feeder cells: 1 h BrdUrd incubation (x 640). B: NHL (ILL) colony; stimulation with
TPA+IL2+feeder cells: 6h BrdUrd incubation (x640). C: NHL (ILL in transf.) colony; stimulation with PHA+IL2+feeder
cells: 24h BrdUrd incubation ( x400). D: HCL colony; stimulation with PHA+IL2+feeder cells: 48h BrdUrd incubation ( x400).B-CELL COLONIES OF MALIGNANT AND NORMAL B-CELLS 403
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Figure 5 Influence of irradiated leukocyte feeders on B-cell colony growth. Each line connects matched colony numbers (mean of
a triplicate culture), obtained from the same experiment, ofcultures on agar with (+) or without (-) leukocyte feeders.
or absence of leukocyte feeders. The results are given in
Figure 5. In the majority of PHA-stimulated cultures (with
or without IL2) strong enhancement of colony formation by
the feeders was found. In contrast, TPA-stimulated cultures
(with or without IL2) showed no enhancement and even in
some cases suppression by leukocyte feeders.
To investigate the growth characteristics of contaminating
T-cells in the culture system, we studied colony formation of
fresh and frozen T-cells from blood of healthy donors and
from one patient with reactive T-cells in pleural fluid. As
expected high numbers of colonies (>80% Eaet-rosette
positive) were obtained after stimulation with PHA +IL2
(fresh 368/105 (n =3); frozen 220/105 (n =2)), PHA alone
(fresh 243/105 (n=7); frozen 176/105 (n=3)) and TPA +IL2
(fresh 75/105 (n=3); frozen 87/105 (n=2)). In contrast,
however, negligible T-cell colony formation was seen after
stimulation with IL2 alone (fresh and frozen 6/105 (n=2))
and TPA alone (fresh 9/105 (n=3); frozen 0/105 (n=2)).
Discussion
Excellent B-cell colony growth was obtained in a majority of
B-cell malignancies and normal B-cells from several sources.
B-cell colony formation has been studied by others with
highly inconsistent results, due to variations in the culture
system (double-layer agar: Jones et al., 1979; Smith et al.,
1981; Hamburger et al., 1984; Fay et al., 1985; double-layer
agarose: Bobak & Whisler, 1980; methylcellulose: Izaguirre
et al., 1980; agar+fluid: Touw et al., 1985a and b), different
stimulatory factors (amongst others, conditioned medium
(CM) of B-cell lines: Jones et al., 1979; Fay et al., 1985; CM
of spleen cells: Jones et al., 1979; CM of PHA-primed T-
cells+T-cell feeders: Izaguirre et al., 1980; Staph. aureus
protein: Bobak & Whisler, 1980; Izaguirre et al., 1980;
Hamburger et al., 1984; Fay et al., 1985), and differences in
definition of colony size, where the minimum number of cells
within a colony ranges from 10 to 50. Therefore, comparison
of our results with those of the literature is not appropriate.
Growth of HCL colonies has been reported in only a few
cases (Izaguirre, 1980; Merchant et al., 1985). However, the
cultures of Merchant et al. were stimulated by PHA without
prior removal of T-cells, thus giving rise to the possibility of
eventual contaminating T-cell growth. We were able to grow
colonies from 5 cases with hairy cell leukaemia although we
also encountered T-cell colony growth in one case.
Since malignant B-cells often grow in an environment
(lymph node, BM, spleen) which contains normal B-lympho-
cytes as well, the clonogenic capacities of these normal B-
cells have also to be studied in the same colony assay. We
were able to grow B-cell colonies from normal blood, BM
and spleen using both fresh and cryopreserved cells. B-cell
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colonies from normal blood have also been obtained by
others (Izaguirre et al., 1980; Bobak & Whisler, 1980;
Hamburger et al., 1984; Fay et al., 1985). B-cell colony
growth from normal BM and spleen has only been studied
by Smith et al. (1981). Their colony assay, in which no
additional stimuli such as mitogens or conditioned media
were applied, proved to be unsuccessful.
It is difficult to prove that the colonies grown in our
system originate from real stem-cells, which by definition
retain a self-renewal capacity (Mackillop et al., 1983; Bizzari
& Mackillop, 1985). We studied self-renewal in 2 cases
(CLL x 1, HCL x 1) by replating colony cells after a primary
growth phase and found secondary colony formation in
both. In the CLL-case the secondary colonies were analysed
and proven to be phenotypically identical to the primary
colonies.
In this colony system, single cells were plated in a fluid
upperlayer, which facilities aggregation of cells, especially in
the presence of PHA ot TPA. Indeed, cell-cell interaction
seems to be necessary to initiate proliferation, since
immobilisation of CLL cells in 0.3% agar did not result in
colony formation (I. Touw, personal communication). The
presence of one or more monocytes in the centre of a colony
also confirms that cell-cell contact occurs. Hairy cells
especially exhibit a strong motility capacity and thus might
form strong aggregates simulating colony formation.
However, we were able to obtain metaphases from colonies
of CLLs, NHLs and HCLs and could demonstrate pro-
nounced BrdUrd incorporation within colonies, which is a
strong indication that cell proliferation is a predominant
factor in colony formation in most cases. Moreover, in
control cultures without additional stimuli colony formation
was usually absent. The observation that (a) in many cases
PHA or TPA only induced colony formation in the presence
of leukocyte feeders and/or IL2, and (b) colonies obtained
from normal polyclonal B-cell suspensions were found to be
light-chain restricted, all provide further evidence for clonal
proliferation.
The majority of our colonies were cultured from cryo-
preserved cells. We found some differences when frozen and
fresh cells were compared, but the clear decrease of T-cell
growth in the frozen suspensions compensated for this
difference (Table II). Moreover, the use of frozen cells
instead of fresh ones makes comparative studies possible. At
the same time, several different B-cell malignancies can be
cultured under identical circumstances. In addition, B-cells
can be obtained from different tumour sites from one patient
or from different stages in the disease and can be studied in
the same experiment. Finally, since the leukocyte feeder
underlayers of the culture system applied need preparation
and an incubation time of at least one day before the cells
are plated, the convenience of working with frozen cells is
obvious.
For non-T ALL and B-CLL colony formation the
requirement of IL2 has been described (Touw et al., 1985b;
Touw & Lowenberg, 1985a). For NHL, HCL and normal
B-cells we could not confirm this. In most cases colonies
were obtained without additional IL2, even in the absence of
leukocyte feeders, which could themselves be a source of
IL2. Preliminary experiments showed that in culture super-
natants of PHA-stimulated leukocyte feeders which had been
kept for 7 days in the incubator, low amounts of IL2 were
present (data not shown). In addition, autocrine production
of IL2 by the malignant B-cells might play a role, although
Rossi et al. (1985) could not confirm this for B-CLL cells.
It is still not known which factors from the leukocyte
feeder layer contribute to the culture system. We methodi-
cally compared colony formation in the presence and
absence of irradiated leukocyte feeders. In most cases,
especially in the presence of PHA, leukocyte feeders contri-
buted to colony formation. The addition of IL2 to PHA was
ineffective. In contrast, in TPA-stimulated cultures (with or
without IL2) the stimulation by leukocyte feeders was far
less pronounced and in many cases leukocyte feeders were
even inhibitory. These differences between PHA and TPA-
mediated colony growth can probably be explained by the
assumption that PHA (and not TPA) present during culture
in the fluid upperlayer, will stimulate the leukocytes in the
agar underlayer to produce additional growth factors.
Indeed, conditioned media prepared from PHA-stimulated
blood leukocytes or from purified T-lymphocytes have been
used by others for B-cell colony growth, thus replacing
stimulating feeder cells during culture (Izaguirre et al., 1980).
Whether PHA-CM can replace irradiated leukocytes in the
agar underlayer is under current study. This would facilitate
the culture system and avoid variations induced by different
leukocyte feeders.
The initial aim of this study was to obtain optimal in vitro
colony growth of a variety of B-cell neoplasms. With the
colony assay described here, the in vitro sensitivity to cyto-
toxic drugs or interferons can be studied. For colonies from
acute myeloblastic leukaemia this PHA leukocyte feeder
colony assay has proven to be successful. Dose-response
curves to the cytotoxic agent ASTA-Z-7557 could be reliably
obtained (Kluin-Nelemans et al., 1984). Another advantage
of this B-cell colony assay is that the phenotypic character-
istics of the clonogenic cell can be documented by cell-
separation procedures. From these experiments the rationale
of BM-purging with MCA for ABMT can be evaluated
(Jansen et al., 1984) at the level of the malignant clonogenic
cells.
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